Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
PRPM now up 42%
NEWS NEGS(OTC) .023 buys PRPM .0007 = share exchange
PRPM up 28% now
NEWS NEGS(OTC) .023 buys PRPM .0007 = share exchange!!!
NEWS NEGS(OTC) .023 buys PRPM .0007 in share exchange!!!
NEWS NEGS(OTC) .023 buys PRPM .0007 in share exchange!!!
Propalms, Inc. Sells Wholly Owned Subsidiary for $2.3 Million
http://ih.advfn.com/p.php?pid=nmona&article=44377764&symbol=PRPM
MSNWQ should pick up steam here!
a few nice movers lately. hope this keeps up through the winter
says it all j$tops. thanks for posting that.
Hey Jason, First let me say I am so sorry for your loss. Your Dad was one of the best in my book. He use to send me his BBQ sauce to taste. One time he sent me two containers, one marked Phil one Jason. He asked me to let him know what i thought of both LOL I told him I couldn't decide so I ended up just mixing them both together! Together they were perfect!
He will be dearly missed. God Bless you and your family
Jenna
yeah i like that part:
thanks! will be checking in each day to check out the plays too :)
nice board. marked
bought some as it bottomed and evey buy showed up as a SELL. MM's playing games with it.
disagree, like me i look at what news hits my scanner each day. IMO they want their news to hit on monday to get a full trading week off that news. but hey JMO WTF do i know :)
but you get more bang for the buck. some people only look at the symbol they are in or are watching for news. lets see what next week brings.
they may be waiting to put the news out on monday. thats what i would do.
Yep news was on the other stock doing the buy out....hasn't showed up on PRPM yet. loaded and ready when it does
PRPM going much higher on BUY OUT news
PRPM grabbed some on that dip. BUY OUT news
same here. the cooler weather can't get here soon enough for me. just getting away from the 97-107 degree days would be nice.
Oh lord, just heard. He use to send me his homemade BBQ sauces to try out. This is a SAD day indeed.
same here. i averaged down to .028. Nice gainer today off that entry point! will wait til i see a re-entry again. Best of luck all!
GDVI got in at .0068, looking for a monster here
congrats all. shaped up to be a nice day here!
INOL alerted again at .028 to LOAD UP!! hope people listened!
INOL dip over she's GOING higher!
INOL load up on small dips here. this baby was over 30005 last week. could do it again here on this neew!!!
yep INOL moves FAST
INOL off the hook here
INOL big gains here!!!!
INOL was up 3000% last week
INOL breaking UPWARD!!!
News for 'INOL' - (InoLife Technologies, Inc. Announces Immediate Availability of the Cytochrome P450 2C1 Plavix Metabolizing Test to the Medical Industry)
RALEIGH, NC, Sep 08, 2010 (MARKETWIRE via COMTEX) -- InoLife Technologies, Inc.
(OTCBB: INOL), a service based healthcare products development, integration and
marketing Company, is extremely pleased that their recently presented Cytochrome
P450 2C1 test to determine a person's ability to metabolize Plavix is
immediately available to the medical industry which includes physicians,
hospitals, medical clinics, and pharmacies. Physicians are currently placing
orders on a daily basis and are incorporating the Cytochrome P450 2C1 Plavix
Metabolizing test into their patients health programs.
InoLife's Cytochrome P450 2C1 test is currently being used to identify how a
patient's genetics may affect the body's response to Plavix (Clopidogrel). The
test is available through the medical community only including physicians,
hospitals, and medical clinics. This test is not available for sale to the
general public.
According to the FDA in a press release dated March 12th, 2010 it is estimated
that 2 percent to 14 percent of the U.S. population are poor metabolizers of
certain medications. In 2009 the Federal Drug Administration approved wording on
the drug label encouraging genetic testing for DNA variants based on specific
risks. It is important to note that this drug metabolism test is not
all-inclusive and is for the physician's guidance only.
InoLife has incorporated the EasiCollect(TM) System, which combines an optimized
foam collection surface with an FTA card for collection of buccal cells and
preservation of DNA. InoLife prides itself in providing the EasiCollect(TM)
System that adheres to the strict guidelines of the Clinical Laboratory
Improvement Amendments (CLIA) that monitors approximately 200,000 laboratory
entities. The Center for Medicare & Medicaid Services regulates all laboratory
testing (except research) performed on humans in the U.S. through CLIA.
About InoLife Technologies, Inc. InoLife is poised to become one of the premier
U.S. marketers of state-of-the-art DNA-based test products. Positioned for
growth and success in a burgeoning market, InoLife Technologies,
www.inolifetech.com, is primarily focused on products, services and solutions
that will enable state-of-the-art healthcare for today and the future for a
diverse base of customers and end users. The Company's mission is to identify,
develop, integrate and bring to market innovative healthcare-based products and
services that provide timely and practical solutions. The primary products and
services that InoLife is currently addressing focuses upon those specific
products and services that provide key solutions through the innovative use of
specific DNA testing and Genetic analysis systems.
The principal customers of InoLife's products and services are healthcare
providers, physicians, practitioners, hospitals and outpatient facilities.
InoLife will be marketing and distributing its products through traditional
distribution channels. Additionally InoLife has developed certain products that
can be sold directly to consumers and has created specific programs to reach
those customers including e-commerce, direct sales, healthcare providers,
pharmacies, distributors, retail sellers and specialty retailers.
(Plavix is a trademark of Bristol-Myers Squibb/Sanofi Pharmaceuticals
Partnership.)
Forward-Looking Statements Safe Harbor Statement under the Private securities
Litigation Reform Act of 1995: The statements contained herein, which are not
historical, are forward-looking statements that are subject to risks and
uncertainties that could cause actual results to differ materially from those
expressed in the forward-looking statements including, but not limited to,
certain delays beyond the Company's control with respect to market acceptance of
new technologies, products and services, delays in testing and evaluation of
products and services, and other risks detailed from time to time in the
Company's filings with the Securities and Exchange Commission.
looking forward to it!
INOL off the bottom today was over 3000% last week. Looks to be starting it's uptrend again
1 x .056 2 x .057
2 x .051 1 x .052